TrialPloS one2014

Safety, tolerability, and immunogenicity of the novel antituberculous vaccine RUTI: randomized, placebo-controlled phase II clinical trial in patients with latent tuberculosis infection.

Andre S Nell et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.